# ResMed Inc. – Consensus ‘buy’ rating and 54.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/resmed-inc.consensus-buy-rating-and-54.7-upside-potential/4121126239
- Published: 2023-08-30T11:30:27+01:00
- Author: Charlotte Edwards

**ResMed Inc.** which can be found using ticker (RMD) have now 10 confirmed analysts
covering the stock with the consensus suggesting a rating of ‘buy’. The range between
the high target price and low target price is between 275 and 207 and has a mean
target at $250.45. Given that the stocks previous close was at $161.88 this would
imply there is now a potential upside of 54.7%. The 50 day moving average now sits
at $201.48 and the 200 day moving average is $215.42. The market cap for the company
is 24.11B. The stock price is currently at: 163.93 USD

 The potential market cap would be $37,300,385,613 based on the market consensus.

The company has a dividend yield of 2.05%. Other points of data to note are a P/
E ratio of 26.87, revenue per share of 28.77 and a 12.15% return on assets.

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged
in the development, manufacturing, distribution and marketing of medical devices
and cloud-based software applications that diagnose, treat and manage respiratory
disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease,
neuromuscular disease and other chronic diseases. It also offers software solutions
for a variety of out-of-hospital care providers. The Company has two segments: Sleep
and Respiratory Care and the Software-as-a-Service. Sleep apnea includes obstructive
sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based
digital health applications, along with its devices, are designed to provide connected
care to improve patient outcomes. The Company’s portfolio of products includes ventilation
devices, diagnostic products, mask systems, headgear and other accessories, dental
devices and cloud-based software informatics solutions.

Share on: